Comparison of ultrasound-assisted and pure fluoroscopy-guided extracorporeal shockwave lithotripsy for renal stones
BMC Urol · 2020 · Vol. 20 · Issue 1 · 183
Academy Summary
Comparison of ultrasound-assisted and pure fluoroscopy-guided extracorporeal shockwave lithotripsy for renal stones examined a clinically important component of shock wave lithotripsy, with particular relevance to SWL Treatment Optimisation.
The evidence comes from a Retrospective Comparative Cohort Study involving adults undergoing swl for renal stones. It reflects clinically relevant experience, but treatment selection and other unmeasured factors may have influenced the observed outcome.
In a retrospective renal-stone cohort, ultrasound-assisted targeting was associated with higher stone-free and disintegration rates and fewer retreatments than fluoroscopy-only guidance, although treatment-system differences may confound the comparison.
A shock generated by the lithotripter is useful only when the stone is within the effective acoustic focus.
The paper belongs to the body of evidence showing that imaging, respiratory motion and focal-zone geometry directly influence how many generated shocks actually reach the stone. Targeting should therefore be treated as a dynamic process rather than a one-time setup step.
Published in 2020, the study should still be interpreted according to its specific lithotripter, patient selection and outcome definitions rather than assumed to represent every modern SWL system.
For the Lithotripsy Academy database, the paper is most useful when interpreted as part of the complete treatment pathway rather than as an isolated numerical rule. Patient selection determines the opportunity for success, while targeting, coupling, shock-wave rate, energy strategy and operator technique determine how effectively that opportunity is converted into fragmentation and clearance.
Comments & Discussion0 comments
Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.
No comments yet. Start the discussion.
Please log in to join the discussion.
